U.S., Jan. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07376460) titled 'Proteomic and Biological Characterisation of Plasma for the Study of Changes Following Ovarian Reactivation Treatment' on Jan. 22.
Brief Summary: The samples used in PRGF treatments owe their effectiveness to the handling, concentration, and preservation of their components, which explains why samples obtained with different platelet-rich plasma preparation systems may vary. At IVIRMA Group, we employ the closed system PRGF-Endoret to process these samples for StemCell Regenera samples obtained after mobilizing stem cells with granulocyte colony-stimulating factor stimulators. According to current regulations, PRP samples are consid...